title: Glycoprotein IIb-IIIa inhibitors - do we still need them?
authors.affiliation: Section Editor, Indian Heart Journal. Electronic address: drkumarvijay@gmail.com.
authors.forename: Vijayakumar
authors.initials: V
authors.lastname: Subban
authors.forename: K
authors.initials: K
authors.lastname: Sarat Chandra
mesh_terms: D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives; D000991:Antithrombins / Q000008:administration & dosage; D003331:Coronary Vessels; D004359:Drug Therapy, Combination; D006629:Hirudins / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial; D009203:Myocardial Infarction / Q000188:drug therapy*; D010446:Peptide Fragments / Q000008:administration & dosage; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage
chemical_list: D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D058921:Purinergic P2Y Receptor Antagonists; D011994:Recombinant Proteins; D000249:Adenosine Monophosphate; C117446:cangrelor; C074619:bivalirudin